(NasdaqGM:IVVD), SPEAR Study Group initiated following multiple, independent reports of substantial clinical benefit associated with PEMGARDA(R) (pemivibart) therapy among people with Long COVID SPEAR Study Group collaborators Drs. Michael Peluso, Amy Proal, and David Putrino are key thought leaders in the clinical and translational biology of Long COVID and Post-Vaccination Syndrome Initial SPEAR clinical efforts […]

(LSE:DEC),(NYSE:DEC), BIRMINGHAM, Ala., July 02, 2025 (GLOBE NEWSWIRE) — Diversified Energy Company PLC (LSE: DEC, NYSE: DEC) (“Diversified” or the “Company”) is pleased to announce the promotion of Michael Garrett to Chief Accounting Officer (“CAO”). Mr. Garrett, a certified public accountant, has been at Diversified since 2018, where he has held various leadership positions and

Invivyd and Leading Researchers Form SPEAR (Spike Protein Elimination and Recovery) Study Group to Assess the Effects of Monoclonal Antibody Therapy for Long COVID and COVID-19 Post-Vaccination Syndrome GlobeNewswire July 02, 2025 SPEAR Study Group initiated following multiple, independent reports of substantial clinical benefit associated with PEMGARDA(R) (pemivibart) therapy among people with Long COVID SPEAR

Diversified Energy Promotes Michael Garrett to Chief Accounting Officer Garrett Brings More Than 20 Years of Accounting and Financial Reporting Experience to the Newly Established Role GlobeNewswire July 02, 2025 BIRMINGHAM, Ala., July 02, 2025 (GLOBE NEWSWIRE) — Diversified Energy Company PLC (LSE: DEC, NYSE: DEC) (“Diversified” or the “Company”) is pleased to announce the

NEW YORK CITY, NY / ACCESS Newswire / July 2, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Elevance Health, Inc. ("Elevance" or "the Company") (NYSE:ELV) and certain of its officers. Class Definition This lawsuit seeks to recover damages against

TSX Venture Exchange: BSKFrankfurt Stock Exchange: MAL2OTCQB Venture Market (OTC):BKUCF Blue Sky Uranium Corp. (TSXV: BSK) (FSE: MAL2) (OTC: BKUCF), (“Blue Sky”or the “Company”) is pleased to announce that it has obtained an additional substantial historic subsurface dataset for its Corcovo Uranium Project an “in situ” recovery (“ISR”) high potential target, located in the Western

Further enhances the company's end-to-end satellite offering as demand for digital constellations grows MDA Space Ltd. (TSX: MDA), a leading provider of advanced technology and services to the rapidly expanding global space industry, today announced that it has completed the previously announced acquisition of SatixFy Communications Ltd. (“SatixFy”), a leader in next-generation satellite communication solutions

The London-based design disruptor teams up with Ceva to power enhanced listening experiences across the Nothing and CMF sub-brand audio product lines, including the newly announced Nothing Headphone (1) In a move that pushes the boundaries of personal audio, Ceva, Inc. (NASDAQ: CEVA), the leading licensor of silicon and software IP for the Smart Edge,

Strategic approach allows Fortress to capitalize on the Fencing and Steel Deck Framing markets Fortress Building Products a trailblazer in outdoor building solutions, backed by Thrive Five Holdings, today announced the sale of Fortress Railing to PrimeSource Brands, a leading North American provider of specialty branded building products. This strategic divestiture enables Fortress to concentrate

CytoSorbents Corporation(NASDAQ: CTSO), a leader in blood purification therapies for life-threatening conditions in the intensive care unit and cardiac surgery, today provided a regulatory update on its marketing applications for DrugSorb™-ATR with the U.S. Food and Drug Administration (FDA) and Health Canada. DrugSorb-ATR is an FDA-designated Breakthrough Device designed to reduce the severity of bleeding